Biosynth Carbosynth Acquires Aalto Bio Reagents
May 26, 2022
Biosynth Carbosynth, a Swiss life‑sciences supplier, has acquired Aalto Bio Reagents, a Dublin‑based developer and provider of biological materials for in‑vitro diagnostics (IVD) and vaccine development. The deal strengthens Biosynth’s IVD and vaccine product portfolio and expands its capabilities to serve diagnostics and vaccine development customers worldwide.
- Buyers
- Biosynth Carbosynth
- Targets
- Aalto Bio Reagents
- Platforms
- Biosynth Carbosynth
- Industry
- Biotechnology
- Location
- Dublin, Ireland
- Transaction Type
- Addon
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.